Arcadia Biosciences (NASDAQ:RKDA) Share Price Crosses Below Fifty Day Moving Average – What’s Next?

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $5.15 and traded as low as $3.74. Arcadia Biosciences shares last traded at $3.81, with a volume of 2,146 shares.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Arcadia Biosciences in a research note on Thursday. They set a “sell” rating on the stock.

Read Our Latest Report on RKDA

Arcadia Biosciences Stock Up 4.1 %

The company has a market cap of $5.20 million, a PE ratio of -0.89 and a beta of 0.88. The firm’s fifty day simple moving average is $5.15 and its 200-day simple moving average is $4.04.

Hedge Funds Weigh In On Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDAFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.